RVPH

Reviva Pharmaceuticals Holdings, Inc.

HealthcareBiotechnologyUSUSDPeers →

$0.63

LiveJun 16, 2026

Market cap

$2.15M

52w range

0.26 – 17.20

P / E

—

EPS

—

Volume

59.4K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Reviva Pharmaceuticals Holdings, Inc.’s valuation

Enterprise value

-$19.57M

Market cap

$2.39M

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-16

Market capitalisation$2.39M

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value-$19.57M

Valuation

· key metrics · TTM

EV / EBITDA—

EV / Sales0.0×

EV / FCF1.0×

Net debt / EBITDA1.3×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage